Wound healing is a complex process of repair that involves the interaction between different cell types and involves coordinated interactions between intracellular and extracellular signaling. Bone Marrow Mesenchymal Stem Cells (BMSCs) based and acellular amniotic membrane (AM) therapeutic strategies with the potential for treatment and regeneration of tissue. We aimed to evaluate the involvement of paracrine effects in tissue repair after the flap skin lesion rat model. In the full-thickness flap skin experiment of forty Wistar rats: A total of 40 male Wistar rats were randomized into four groups: group I: control (C; n = 10), with full-thickness lesions on the back, without (BMSCs) or AM (n = 10); group II: injected (BMSCs; n = 10); group III: covered by AM; group IV–injected (AM + BMSCs; n = 10). Cytokine levels, IL-1, and IL-10 assay kits, superoxide dismutase (SOD), glutathione reductase (GRs) and carbonyl activity levels were measured by ELISA 28th day, and TGF-β was evaluated by immunohistochemical, the expression collagen expression was evaluated by Picrosirius staining. Our results showed that the IL-1 interleukin was higher in the control group, and the IL-10 presented a higher mean when compared to the control group. The groups with BMSCs and AM showed the lowest expression levels of TGF-β. SOD, GRs, and carbonyl activity analysis showed a predominance in groups that received treatment from 80%. The collagen fiber type I was predominant in all groups; however, the AM + BMSCs group obtained a higher average when compared to the control group. Our findings suggest that the AM+ BMSCs promote skin wound healing, probably owing to their paracrine effect attributed to the promotion of new collagen for tissue repair.
1 January 2023 in Brazilian Archives of Biology and Technology
Bovine Leukemia Virus (BLV) is a delta retrovirus widely distributed in cattle populations worldwide and is responsible for enzootic bovine leukosis, resulting in significant economic losses in the livestock industry. In recent years, increasing scientific interest has emerged regarding the potential implications of BLV beyond animal health, particularly within the One Health framework. This mini-review summarizes recent evidence (2020-2025) concerning BLV epidemiology, transmission routes, diagnostic advances, and potential interfaces between animal and human health. Recent studies have reported the detection of BLV DNA or antibodies in human tissues and blood samples, raising questions about possible human exposure. However, current evidence does not demonstrate active infection or a causal role of BLV in human disease. Therefore, while the available data suggests potential exposure pathways, the zoonotic significance of BLV remains uncertain. Continued interdisciplinary research integrating veterinary surveillance, molecular epidemiology, and public health perspectives will be essential to clarify the biological and epidemiological relevance of these findings.